HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.

Abstract
GR32191, a potent selective thromboxane receptor antagonist, has been shown to inhibit completely prostaglandin endoperoxide and thromboxane A2 (TxA2)-induced platelet aggregation, [14C]-serotonin secretion and beta-thromboglobulin secretion. Deposition of human platelets onto damaged rabbit aorta in vitro is reduced in the presence of GR32191 which appears to inhibit aggregation of platelets but not direct adhesion of platelets to subendothelium. The effects of non-prostanoid platelet activating agents whose mode of action requires the biosynthesis of TxA2 are also inhibited by GR32191. Prostanoids which inhibit platelet function, such as prostacyclin or PGD2, retain their inhibitory properties in the presence of GR32191 which does not inhibit phospholipase A2, prostaglandin cyclooxygenase, thromboxane synthase, 12-lipoxygenase or cAMP phosphodiesterase activity. The inhibitory action of GR32191 on platelet aggregation, mural thrombus formation and platelet protein storage granule secretion suggests that it has potential in treating thrombotic disease in man.
AuthorsE J Hornby, M R Foster, P J McCabe, L E Stratton
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 61 Issue 3 Pg. 429-36 (Jun 30 1989) ISSN: 0340-6245 [Print] Germany
PMID2529661 (Publication Type: Journal Article)
Chemical References
  • Biphenyl Compounds
  • Enzyme Inhibitors
  • Heptanoic Acids
  • Platelet Aggregation Inhibitors
  • Receptors, Prostaglandin
  • Receptors, Thromboxane
  • beta-Thromboglobulin
  • Serotonin
  • Thromboxane B2
  • vapiprost
Topics
  • Biphenyl Compounds (pharmacology)
  • Blood Platelets (drug effects, enzymology, metabolism)
  • Enzyme Inhibitors (pharmacology)
  • Heptanoic Acids (pharmacology)
  • Humans
  • Platelet Adhesiveness (drug effects)
  • Platelet Aggregation (drug effects)
  • Platelet Aggregation Inhibitors (pharmacology)
  • Receptors, Prostaglandin
  • Receptors, Thromboxane
  • Serotonin (blood)
  • Thromboxane B2 (biosynthesis, metabolism)
  • beta-Thromboglobulin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: